Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Efficacy, Safety, and Pharmacokinetics/Pharmacodynamic Relationship Study of L-Dopa/Carbidopa in a Novel Release Formulation in Parkinson's Disease Patients

NCT00558337 is registered in ClinicalTrials.gov with Osmotica Pharmaceutical US LLC as lead sponsor.

NCT NCT00558337
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00558337 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Efficacy, Safety, and Pharmacokinetics/Pharmacodynamic Relationship Study of L-Dopa/Carbidopa in a Novel Release Formulation in Parkinson's Disease Patients
Lead sponsor
Osmotica Pharmaceutical US LLC
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2007
Completion date
December 31, 2008
Enrollment
78 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson's disease